Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia
Objective: Our focus was on comparing the performance of CDT and MMSE in Parkinson’s Disease Dementia (PDD) and Alzheimer’s Disease (AD) patients. Background: The mini…Clinical characteristics of pain in Parkinson’s disease dementia
Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…When and how to stop subthalamic deep brain stimulation in late-stage Parkinson’s disease
Objective: We sought to investigate the percentage of “poor stimulation responders” among late-stage Parkinson's disease (LSPD) patients for elaborating an algorithm to decide whether and…DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead
Objective: The study proposed a new Deep Brain Stimulation (DBS) approach in Parkinson´s disease (PD): the Globus pallidus pars interna (GPi) + Nucleus Basalis of…Cognitive impairment in Parkinson’s Disease: A cross-sectional association study
Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…Combined STN and NBM DBS in PD and mild to moderate Parkinson’s dementia
Objective: While deep brain stimulation (DBS) of the subthalamic nucleus (STN) alleviates Parkinson"s Disease(PD) related motor symptoms, to date PD dementia (PDD) patients are excluded…The influence of baseline body mass index on cognitive decline in Parkinson’s disease
Objective: The aim of this study is to know whether the baseline BMI is associated with cognitive decline and future development of dementia. Background: Alterations…High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools
Objective: To set up a robust (see ref 1 for definition) 96-well High Content Screening assay of synucleinopathy in primary cultures of cortical neurons. Background:…Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population
Objective: To describe healthcare resource use (HCRU) and related costs among Parkinson’s patients with dementia (PDD) and psychosis compared with other dementia types in a…Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements
Objective: To compare the regional distribution of cortical tau pathology between Lewy body disorders (LBD: Parkinson’s disease and dementia with Lewy bodies (DLB)) and progressive…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »